Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T14:47:01.824Z.
Calculation as of: 2026-10-06T14:47:01.824Z.
Quote observation: 2026-10-06T14:45:13.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 451a64ce4da380df6ab4c5027584c6fd3c25ecc0cb3c19eab7daced69cd0f5b9
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Grace Therapeutics, Inc.
Market Cap
$33.93M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$32.86M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$32.78M
Operating Cash Flow Yield
N/A
TTM Avg
0.20%
3Y Avg
0.20%
5Y Avg
0.20%
Market Cap
$34.89M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$31.47M
Operating Cash Flow Yield
9.75%
TTM Avg
9.00%
3Y Avg
11.41%
5Y Avg
14.06%
Market Cap
$35.75M
Operating Cash Flow Yield
N/A
TTM Avg
13.07%
3Y Avg
8.54%
5Y Avg
8.65%
Market Cap
$31.36M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $33.93M | N/A | N/A | N/A | N/A |
| HeartBeam, Inc. (BEAT)vs › | $33.42M | N/A | N/A | N/A | N/A |
| Aligos Therapeutics, Inc. (ALGS)vs › | $32.86M | N/A | N/A | N/A | N/A |
| EUDA Health Holdings Limited (EUDA)vs › | $32.78M | N/A | 0.20% | 0.20% | 0.20% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $34.89M | N/A | N/A | N/A | N/A |
| Elutia Inc (ELUT)vs › | $34.92M | N/A | N/A | N/A | N/A |
| Nortech Systems Incorporated (NSYS)vs › | $31.47M | 9.75% | 9.00% | 11.41% | 14.06% |
| Accuray Incorporated (ARAY)vs › | $35.75M | N/A | 13.07% | 8.54% | 8.65% |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.36M | N/A | N/A | N/A | N/A |
| Context Therapeutics Inc. (CNTX)vs › | $30.63M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
